ABCB1 SNP rs4148738 modulation of apixaban interindividual variability

被引：37

作者：

Dimatteo, Claudia ^{[1
]}

D'Andrea, Giovanna ^{[1
]}

Vecchione, Gennaro ^{[2
]}

Paoletti, Oriana ^{[3
]}

Tiscia, Giovanni Luca ^{[2
]}

Santacroce, Rosa ^{[1
]}

Correale, Michele ^{[4
]}

Brunetti, Natale ^{[4
]}

Grandone, Elvira ^{[2
]}

Testa, Sophie ^{[3
]}

Margaglione, Maurizio ^{[1
]}

机构：

[1] Univ Foggia, Dept Clin & Expt Med, Med Genet, Viale Pinto, I-71122 Foggia, Italy

[2] IRCCS Casa Sollievo Sofferenza, Atherosclerosis & Thrombosis Unit, San Giovanni Rotondo, Italy

[3] AO Ist Ospitalieri, Dept Lab Med, Haemostasis & Thrombosis Ctr, Cremona, Italy

[4] Univ Foggia, Dept Med & Surg Sci, Cardiol, Foggia, Italy

来源：

THROMBOSIS RESEARCH | 2016年 / 145卷

关键词：

FACTOR XA INHIBITOR; HEALTHY-SUBJECTS; PHARMACODYNAMICS; PHARMACOKINETICS; SAFETY;

D O I：

10.1016/j.thromres.2016.07.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：24 / 26

页数：3

共 10 条

[1]

Bristol-Myers Squib Canada, 2015, EL AP PROD MON

[2]

Bristol-Myers Squibb Company, 2015, ELIQUIS AP TABL OR U

[3] ABCB1 pharmacogenetics:: Progress, pitfalls, and promise [J].

Chinn, L. W. ;

Kroetz, D. L. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :265-269

[4]

D'Ambrosio RL, 2004, HAEMATOLOGICA, V89, P1510

[5] Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: Application to pharmacokinetic study [J].

Delavenne, Xavier ;

Mismetti, Patrick ;

Basset, Thierry .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 78-79 :150-153

[6] Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects [J].

Frost, Charles ;

Nepal, Sunil ;

Wang, Jessie ;

Schuster, Alan ;

Byon, Wonkyung ;

Boyd, Rebecca A. ;

Yu, Zhigang ;

Shenker, Andrew ;

Barrett, Yu Chen ;

Mosqueda-Garcia, Rogelio ;

LaCreta, Frank .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) :776-786

[7] Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects [J].

Frost, Charles ;

Wang, Jessie ;

Nepal, Sunil ;

Schuster, Alan ;

Barrett, Yu Chen ;

Mosqueda-Garcia, Rogelio ;

Reeves, Richard A. ;

LaCreta, Frank .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (02) :476-487

[8] The syntheses and in vitro biotransformation studies of [14C]apixaban, a highly potent, selective, efficacious and orally bioavailable inhibitor of blood coagulation Factor Xa [J].

Maxwell, Brad D. ;

Tran, Scott B. ;

Chen, Shiang-Yuan ;

Zhang, Donglu ;

Chen, Bang-Chi ;

Zhang, Huiping ;

Bonacorsi, Samuel J., Jr. .

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 (08) :418-425

[9] Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding [J].

Pare, Guillaume ;

Eriksson, Niclas ;

Lehr, Thorsten ;

Connolly, Stuart ;

Eikelboom, John ;

Ezekowitz, Michael D. ;

Axelsson, Tomas ;

Haertter, Sebastian ;

Oldgren, Jonas ;

Reilly, Paul ;

Siegbahn, Agneta ;

Syvanen, Ann-Christine ;

Wadelius, Claes ;

Wadelius, Mia ;

Zimdahl-Gelling, Heike ;

Yusuf, Salim ;

Wallentin, Lars .

CIRCULATION, 2013, 127 (13) :1404-+

[10] Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans [J].

Raghavan, Nirmala ;

Frost, Charles E. ;

Yu, Zhigang ;

He, Kan ;

Zhang, Haiying ;

Humphreys, W. Griffith ;

Pinto, Donald ;

Chen, Shiangyuan ;

Bonacorsi, Samuel ;

Wong, Pancras C. ;

Zhang, Donglu .

DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) :74-81

← 1 →